ATC Group: L01CB02 Teniposide

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of L01CB02 in the ATC hierarchy

Level Code Title
1 L Antineoplastic and immunomodulating agents
2 L01 Antineoplastic agents
3 L01C Plant alkaloids and other natural products
4 L01CB Podophyllotoxin derivatives
5 L01CB02 Teniposide

Active ingredients in L01CB02

Active Ingredient Description
Teniposide

Teniposide is a phase-specific cytotoxic drug, acting in the late S or early G2 phase of the cell cycle, thus preventing cells from entering mitosis. Teniposide has a broad spectrum of in vivo antitumor activity against murine tumors, including hematologic malignancies and various solid tumors.

Medicines in this ATC group

Brazil (BR)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.